Skip to main content
Top
Published in: Rheumatology International 7/2008

01-05-2008 | Case Report

Epidural hematoma mimicking transverse myelitis in a patient with primary antiphospholipid syndrome

Authors: W. J. Kim, Y. K. Hong, Wan-Hee Yoo

Published in: Rheumatology International | Issue 7/2008

Login to get access

Abstract

Antiphospholipid syndrome (APS) is an autoimmune disease, and its most critical pathologic process is thrombosis, which may explain most of the clinical features. Acute management of thrombosis involves immediate anticoagulation. Acute proximal venous thrombosis can be managed with thrombolytic therapy to reduce the long-term complications of the postthrombotic syndrome (pain, swelling, skin discoloration, or ulceration) and perform recanalization of occluded vessels. However, thrombolytic therapies are associated with high risks of bleeding. To our knowledge, this is the first report of epidural hematoma mimicking transverse myelitis after catheter-directed thrombolysis in a patient with primary APS. A 42-year-old male was admitted with sudden onset pain and swelling on left lower extremity. Venography demonstrated multiple thrombi on superficial femoral vein, common femoral vein, common iliac vein, and external iliac vein. Laboratory tests indicated the presence of IgM anticardiolipin antibody. He was diagnosed with primary APS with multiple venous thrombi. He was treated with urokinase (200,000/h) as thrombolytic therapy. After 1 day, he complained both leg weakness and urinary dysfunction. T1- and T2-weighted magnetic resonance images of spine showed about 8 cm-sized mass, suggesting hematoma on the posterior epidural space at thoracolumbar area. Despite the successful evacuation of hematoma, neurologic symptoms persisted and he is now receiving aspirin, warfarin, and physical therapy.
Literature
1.
2.
go back to reference Bertolaccini ML, Khamashta MA, Hughes GR (2005) Diagnosis of antiphospholipid syndrome. Nat Clin Pract Rheumatol 1:40–46PubMedCrossRef Bertolaccini ML, Khamashta MA, Hughes GR (2005) Diagnosis of antiphospholipid syndrome. Nat Clin Pract Rheumatol 1:40–46PubMedCrossRef
3.
go back to reference Petri M, Qazi U (2006) Management of antiphospholipid syndrome in pregnancy. Rheum Dis Clin North Am 32:591–607PubMedCrossRef Petri M, Qazi U (2006) Management of antiphospholipid syndrome in pregnancy. Rheum Dis Clin North Am 32:591–607PubMedCrossRef
4.
go back to reference Bertolaccini ML, Khamashta MA (2006) Laboratory diagnosis and management challenges in the antiphospholipid syndrome. Lupus 15:172–178PubMedCrossRef Bertolaccini ML, Khamashta MA (2006) Laboratory diagnosis and management challenges in the antiphospholipid syndrome. Lupus 15:172–178PubMedCrossRef
5.
go back to reference Huang HJ, Wang JN, Tsai YC, Lin CS, Wu JM (2002) Intrapulmonary thrombolytic therapy in a child with acute pulmonary embolism due to primary antiphospholipid syndrome. Acta Paediatr Taiwan 43:351–353PubMed Huang HJ, Wang JN, Tsai YC, Lin CS, Wu JM (2002) Intrapulmonary thrombolytic therapy in a child with acute pulmonary embolism due to primary antiphospholipid syndrome. Acta Paediatr Taiwan 43:351–353PubMed
6.
go back to reference La Milia V, Tentori F, Pozzi C, Taddei G, Locatelli F (1998) Primary antiphospholipid antibody syndrome with membranous obstruction of the inferior vena cava-successful PTA and thrombolytic therapy. Nephrol Dial Transplant 13:2641–2644PubMedCrossRef La Milia V, Tentori F, Pozzi C, Taddei G, Locatelli F (1998) Primary antiphospholipid antibody syndrome with membranous obstruction of the inferior vena cava-successful PTA and thrombolytic therapy. Nephrol Dial Transplant 13:2641–2644PubMedCrossRef
7.
go back to reference Watson LI, Armon MP (2004) Thrombolysis for acute deep vein thrombosis. Cochrane Database Syst Rev 18:CD002783 Watson LI, Armon MP (2004) Thrombolysis for acute deep vein thrombosis. Cochrane Database Syst Rev 18:CD002783
8.
go back to reference Bjarnason H, Kruse JR, Asinger DA, Nazarian GK, Dietz CA, Caldwell MD et al (1997) Iliofemoral deep venous thrombosis: safety and efficacy outcome during 5 years of catheter-directed thrombolytic therapy. J Vasc Interv Radiol 8:405–418PubMedCrossRef Bjarnason H, Kruse JR, Asinger DA, Nazarian GK, Dietz CA, Caldwell MD et al (1997) Iliofemoral deep venous thrombosis: safety and efficacy outcome during 5 years of catheter-directed thrombolytic therapy. J Vasc Interv Radiol 8:405–418PubMedCrossRef
9.
go back to reference Miyakis S, Lockshin MD, Atsumi T et al (2006) International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 4:295–306PubMedCrossRef Miyakis S, Lockshin MD, Atsumi T et al (2006) International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 4:295–306PubMedCrossRef
10.
go back to reference Semba CP, Dake MD (1996) Catheter-directed thrombolysis for iliofemoral venous thrombosis. Semin Vasc Surg 9:26–33PubMed Semba CP, Dake MD (1996) Catheter-directed thrombolysis for iliofemoral venous thrombosis. Semin Vasc Surg 9:26–33PubMed
11.
go back to reference Alesh I, Kayali F, Stein PD (2007) Catheter-directed thrombolysis (intrathrombus injection) in treatment of deep venous thrombosis: a systematic review. Catheter Cardiovasc Interv 70:143–148PubMedCrossRef Alesh I, Kayali F, Stein PD (2007) Catheter-directed thrombolysis (intrathrombus injection) in treatment of deep venous thrombosis: a systematic review. Catheter Cardiovasc Interv 70:143–148PubMedCrossRef
12.
go back to reference Chang R, Cannon RO III, Chen CC, Doppman JL, Shawker TH, Mayo DJ et al (2001) Daily catheter-directed single dosing of t-PA in treatment of acute deep venous thrombosis of the lower extremity. J Vasc Interv Radiol 12:247–252PubMedCrossRef Chang R, Cannon RO III, Chen CC, Doppman JL, Shawker TH, Mayo DJ et al (2001) Daily catheter-directed single dosing of t-PA in treatment of acute deep venous thrombosis of the lower extremity. J Vasc Interv Radiol 12:247–252PubMedCrossRef
13.
go back to reference Horne MK III, Mayo DJ, Cannon RO III, Chen CC, Shawker TH, Chang R (2000) Intraclot recombinant tissue plasminogen activator in the treatment of deep venous thrombosis of the lower and upper extremities. Am J Med 108:251–255PubMedCrossRef Horne MK III, Mayo DJ, Cannon RO III, Chen CC, Shawker TH, Chang R (2000) Intraclot recombinant tissue plasminogen activator in the treatment of deep venous thrombosis of the lower and upper extremities. Am J Med 108:251–255PubMedCrossRef
14.
go back to reference Schweizer J, Kirch W, Koch R, Elix H, Hellner G, Forkmann L et al (2000) Short- and long-term results after thrombolytic treatment of deep venous thrombosis. J Am Coll Cardiol 36:23–27CrossRef Schweizer J, Kirch W, Koch R, Elix H, Hellner G, Forkmann L et al (2000) Short- and long-term results after thrombolytic treatment of deep venous thrombosis. J Am Coll Cardiol 36:23–27CrossRef
15.
go back to reference Kim JH, Lee SI, Park SI, Yoo WH (2004) Recurrent transverse myelitis in primary antiphospholipid syndrome—case report and literature review. Rheumatol Int 24:24424–24426 Kim JH, Lee SI, Park SI, Yoo WH (2004) Recurrent transverse myelitis in primary antiphospholipid syndrome—case report and literature review. Rheumatol Int 24:24424–24426
16.
go back to reference Lee DM, Jeon HS, Yoo WH (2003) Transverse myelitis in a patient with primary antiphospholipid syndrome. Yonsei Med J 44:323–327PubMed Lee DM, Jeon HS, Yoo WH (2003) Transverse myelitis in a patient with primary antiphospholipid syndrome. Yonsei Med J 44:323–327PubMed
17.
go back to reference Nomura Y, Takatsu R, Fujisawa K, Kamo T, Sugihara H (1999) A case of transverse myelitis caused by primary antiphospholipid antibody syndrome. Rinsho Shinkeigaku 39:976–978PubMed Nomura Y, Takatsu R, Fujisawa K, Kamo T, Sugihara H (1999) A case of transverse myelitis caused by primary antiphospholipid antibody syndrome. Rinsho Shinkeigaku 39:976–978PubMed
Metadata
Title
Epidural hematoma mimicking transverse myelitis in a patient with primary antiphospholipid syndrome
Authors
W. J. Kim
Y. K. Hong
Wan-Hee Yoo
Publication date
01-05-2008
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 7/2008
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-007-0512-5

Other articles of this Issue 7/2008

Rheumatology International 7/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.